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NLR proteins play seminal roles in innate immunity. In particular, NOD1 (NLRC1) activates various signaling pathways including
NF-kB in response to bacterial ligands. NOD1 polymorphisms are associated with several human inflammatory disorders including
sarcoidosis, Crohn’s disease, asthma, and autoimmune uveitis. Here, Correa et al. identify an inaugural class of 2-aminobenzimida-
zole compounds that selectively inhibit NOD1. Mechanistic studies of the prototypical compound Nodinitib-1 suggest that these
molecules modulate NOD1 conformation and alter its subcellular localization. This inhibitor class constitutes chemical probes for
interrogating mechanisms regulating NOD1 activity and tools for exploring the roles of NOD1 in various pathological conditions.Supercharged Human Proteins Take on the Delivery Job
PAGE 833
Macromolecules have become essential research tools and important human therapeutics but are limited by their general inability
to cross cell membranes. Here, Cronican et al. searched for naturally supercharged human proteins (proteins with unusually high
positive charge) and discovered a substantial class that potently deliver proteins in their functional form into mammalian cells
both in vitro and also in murine retina, pancreas, and white adipose tissues in vivo. These proteins represent diverse macromolecule
delivery agents for in vivo applications and also raise the possibility that they may possess native biological functions associated with
their ability to penetrate cells.Peptide Tools for Angiogenesis
PAGE 839
In order to support on-going efforts in antiangiogenesis therapy and personalized medicine, Fedorova
et al. used phage display to develop peptides that selectively recognizes vascular endothelial growth
factor (VEGF) with nanomolar potency. The mode of VEGF recognition of the peptides was determined
by high resolution X-ray crystal analysis. Using positron emission tomography, the show that radio-
labeled peptides provided images of growing tumors in animal models 2 hr postinjection, which
are comparable to images that were obtained 72 hr postinjection using a radio-labeled anti-VEGF
antibody.Disrupting MAGL: Double Blow for Aggressive Cancers
PAGE 846
Characterizing the metabolic pathways that tumor cells use to support their malignant behavior is important for understanding
and treating cancer. It has been shown that the lipolytic enzyme MAGL is elevated in aggressive breast, ovarian, and melanoma
cancer cells, where it regulates a fatty acid network enriched in protumorigenic signaling lipids. Here, Nomura et al. show that
MAGL is highly expressed in aggressive prostate cancer cells, in which it not only regulates protumorigenic fatty acid products,
but also suppresses antitumorigenic endocannabinoid signals. Disrupting the MAGL pathway impairs tumor aggressiveness and
offers a novel way to treat aggressive forms of cancer.Antimicrobial Peptide Biosynthesis
PAGE 857
Lantibiotics are ribosomally synthesized and posttranslationally modified antimicrobial peptides. The recently discovered lantibiotic
epilancin 15X produced by Staphylococcus epidermidis 15X154 contains an unusual N-terminal lactate group. In this study,
Vela´squez et al. elucidate the biosynthetic route towards epilancin 15X and demonstrate the activities of a serine-type leader peptide
protease and a short-chain dehydrogenase/reductase involved in lactate formation in vitro. Furthermore, they show that the
N-terminal lactate confers stability against proteolytic degradation by aminopeptidases, a feature that may be applied for the
engineering of novel lantibiotics.High-Throughput Kinase Profiling for Inhibitor Discovery
PAGE 868
Selective protein kinase inhibitors have only been developed against a small number of kinase targets.
Here, Miduturu et al. demonstrate that ‘‘high-throughput kinase profiling’’ of a library of 118 compounds
constituting two distinct scaffolds is an efficient method for the discovery of lead compounds, both for
established aswell as unexplored kinase targets. They identified selective inhibitors with submicromolar
cellular activity against various kinases. This inhibitor-centric approach permits a comprehensive
assessment of a scaffold of interest and represents an efficient and general strategy for identifying
new selective kinase inhibitors.Chemistry & Biology 18, July 29, 2011 ª2011 Elsevier Ltd All rights reserved ix
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Many cellular processes rely on Ca2+ signals to maintain healthy function. The ability to controllably
generate local and global Ca2+ signals thus facilitates the investigation of underlying Ca2+ signaling that
regulates cellular processes in healthy versus pathogenic cells. Here, Pham et al. developed LOVS1K,
a genetically encoded and photoactivated synthetic protein that generates local or global Ca2+ signals
through binding to Orai1, a Ca2+-specific membrane channel. This photoactivated system can be used
to generate spatially and temporally precise Ca2+ signals and to engineer synthetic proteins that respond
to specific Ca2+ signals.Role of AAK1 in Neurotrophic Factor Signaling
PAGE 891
Identifying small molecules that target neurotrophic factor signaling may lead to novel therapeutics for a variety of nervous system
disorders that involve altered brain plasticity. Here, Kuai et al. use an integrative quantitative proteomic and RNAi-mediated
gene silencing strategy to identify adaptor-associated kinase 1 (AAK1) as a target of the indolocarbazole natural product K252a,
which plays a critical role in the regulation of Nrg1/ErbB4-dependent neurotrophic factor signaling. These studies provide new insight
into themolecular mechanisms that regulate neurotrophic factor signaling andmay lead to novel approaches to regulate Nrg1/ErbB4
signaling in the brain.Siderophore Promiscuity
PAGE 907
Iron acquisition is crucial for survival and virulence of almost all microorganisms. Therefore, they secrete
low molecular weight iron chelators, called siderophores, to mobilize iron from the environment. Iron-
loaded siderophores are reimported into the cell by ATP-binding cassette transporters. The elucidation
of the capture mechanism for different siderophores by the cognate transporter binding proteins is
crucial for the potential development of new transporter-targeted antibiotics. Here, Peuckert et al.
investigate the structural and stereochemical requirements for import of the prominent siderophore
enterobactin and its synthetic analog mecam by X-ray crystallography and supporting iron uptake
and mutational studies in vivo.p53 Inactivation with Lipidic Aldehydes
PAGE 920
Cancer and inflammation are known to be intrinsically linked pathologies in vivo; however, the chemical processes that underpin this
linkage are largely unknown. Here, Nieva et al. show that direct modification of p53 by certain endogenous lipidic aldehydes, which
are generated during inflammation, is sufficient to cause structural changes in p53 that may contribute to epigenetic silencing. This
direct inactivation of p53 by cholesterol-derived aldehydes may therefore constitute a hitherto unknown chemical link between
inflammation and cancer and may contribute in part to the cancers in which inactivation of wild-type p53 is a key component.tRNA Folding: Cooperative Effects of Nucleotide Modifications
PAGE 928
Using advanced RNA synthesis techniques and single molecule spectroscopy, Kobitski et al. describe the deconvolution of the
individual contributions of posttranscriptional modifications to the overall folding and stabilization of tRNA. They find that the
presence of m2G10 alone does not facilitate the folding of tRNALys, but that a stabilization of the biologically functional cloverleaf
shape in conjunction with the principal stabilizing component m1A9 exceeds the contribution of m1A. This constitutes an unprece-
dented cooperative effect of nucleotidemodifications in a naturally occurring RNA, whichmay be important for tRNA structure and for
understanding the decay pathways of hypomodified tRNAs., July 29, 2011 ª2011 Elsevier Ltd All rights reserved
